Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) | SANOFI PASTEUR | 1 | — | OT |
inappropriate use due to nurse administered TYPHIM VI to a patient 9 months early with no reported adverse event; Initial information received on 22-Jul-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient with inappropriate use due to nurse administered Typhoid Vi Polysaccharide Vaccine [Typhim Vi]9 months early with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in March 2024, the patient received a Dose 1 of suspect Typhoid Vi Polysaccharide Vaccine Solution for injection (strength, dose, batch and expiry date unknown) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation). On 21-Jul-2025 he/she again received Dose 2 of same vaccine with an unknown batch number via unknown route in unknown administration site, inappropriate use due to nurse administered typhim vi to a patient 9 months early with no reported adverse event (inappropriate schedule of product administration) (latency same day). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Reportedly, the patient had already gotten the vaccine in Mar-2024 and the nurse administered it yesterday instead of waiting until Mar-2026 Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.